Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2007
Report date:
2007

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
2004
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
2002
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3-bromo-5-chlorophenol
EC Number:
611-435-6
Cas Number:
56962-04-0
Molecular formula:
C6H4BrClO
IUPAC Name:
3-bromo-5-chlorophenol

Test animals

Species:
rat
Strain:
Crj: CD(SD)
Sex:
female
Details on test animals or test system and environmental conditions:
Charles River Laboratories, Research Models and Services, Germany GmbH, Sanhofer Weg 7, 97633 Sulzfeld, Germany
Body weight: 177-190 g
Age 52-53 days

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: Sesame Oil
Doses:
2000 mg/kg b.w.
No. of animals per sex per dose:
6
Details on study design:
Duration of experiment: 5 adaptation days; 1 test day; 2 recovery weeks
Frequency of observations: before and immediately, 5, 15, 30, and 60 min as well as 3, 6, and 24 hours after adminsitration

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
none
Clinical signs:
none
Body weight:
177-190 g (at start administration)
Gross pathology:
No changes were noted at necropsy.

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Remarks:
Migrated information
Conclusions:
Under the present test conditions, a single oral administration of 2000 mg/kg b.w. to rats did not reaveal any changes. No mortality occured. No clinical signs were observed. All animals gained the expected body weight throughout the whole study period. No changes were noted at necropsy. The LD50 value was ranked exceeding 2000 mg/kg b.w..